ASH 2017 - dr. H. Leitch

Iron Overload in Lower International Prognostic Scoring System Risk Myelodysplastic Syndromes Patients Receiving Red Blood Cell Transfusions: Relation to Infection and Possible Benefit of Iron Chelation Therapy

 

Dr. H. Leitsch geeft een weergave van de studie: "Iron Overload in Lower International Prognostic Scoring System Risk Myelodysplastic Syndromes Patients Receiving Red Blood Cell Transfusions: Relation to Infection and Possible Benefit of Iron Chelation Therapy" die zij tijdens de ASH 2017 heeft gepresenteerd
 

0419HEM1133668
×

Ask Speakers

×

Medical Information Request